ACLX Q3 2022 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$94M

Net Income

-$93M

EPS (Diluted)

$-2.12

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$337M

Total Liabilities

$101M

Stockholders' Equity

$236M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$94M	-$17M	-448.7%
Net Income	-$93M	-$17M	-443.4%